LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1857 | 4405 | 0.4227 | 0.2484 |
MDA-MB-231 | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 1747 | 4405 | 0.3972 | 0.2075 |
MDA-MB-231 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1317 | 4405 | 0.2981 | 0.0312 |
MDA-MB-231 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1235 | 562 | 4405 | 0.1271 | -0.3529 |
MDA-MB-231 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4652 | 4405 | 1.0561 | 1.0606 |
MDA-MB-231 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4569 | 4405 | 1.0357 | 1.0366 |
MDA-MB-231 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4437 | 4405 | 1.0064 | 1.0061 |
MDA-MB-231 | Sorafenib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4641 | 4405 | 1.0524 | 1.0551 |
MDA-MB-231 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 4497 | 4405 | 1.0199 | 1.0206 |
MDA-MB-231 | Sorafenib | 10 | uM | LJP6 | 72 | hr | 1235 | 3819 | 4405 | 0.8659 | 0.8475 |
MDA-MB-231 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4695 | 4660 | 1.0072 | 1.0072 |
MDA-MB-231 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4537 | 4660 | 0.9728 | 0.9699 |
MDA-MB-231 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3084 | 4660 | 0.6557 | 0.3293 |
MDA-MB-231 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4178 | 4660 | 0.8982 | 0.8911 |
MDA-MB-231 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 3791 | 4660 | 0.8141 | 0.7963 |
MDA-MB-231 | CP466722 | 10 | uM | LJP5 | 72 | hr | 1235 | 2241 | 4660 | 0.4818 | 0.3650 |
MDA-MB-231 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4774 | 4660 | 1.0275 | 1.0295 |
MDA-MB-231 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4689 | 4660 | 1.0083 | 1.0096 |
MDA-MB-231 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4612 | 4660 | 0.9914 | 0.9915 |
MDA-MB-231 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4619 | 4660 | 0.9931 | 0.9935 |
MDA-MB-231 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4353 | 4660 | 0.9346 | 0.9309 |
MDA-MB-231 | CP724714 | 10 | uM | LJP5 | 72 | hr | 1235 | 4324 | 4660 | 0.9306 | 0.9269 |
MDA-MB-231 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1086 | 4405 | 0.2461 | -0.0705 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 517 | 4405 | 0.1174 | -0.3787 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 470 | 4405 | 0.1069 | -0.4121 |